| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 3.882 | 45.411 | 125.702 | 166.808 | 132.887 | 137.793 | 119.111 | 111.568 | 145.293 |
| Total Income - EUR | 0 | 3.882 | 45.411 | 125.702 | 166.808 | 132.887 | 137.793 | 119.111 | 132.351 | 145.293 |
| Total Expenses - EUR | 0 | 4.386 | 36.035 | 78.298 | 99.137 | 83.682 | 93.696 | 93.243 | 106.888 | 110.245 |
| Gross Profit/Loss - EUR | 0 | -504 | 9.376 | 47.404 | 67.671 | 49.206 | 44.097 | 25.868 | 25.463 | 35.048 |
| Net Profit/Loss - EUR | 0 | -582 | 8.922 | 46.148 | 66.003 | 48.221 | 43.002 | 24.705 | 24.166 | 31.410 |
| Employees | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Schmidt Pharmamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 108 | 424 | 503 | 493 | 2.163 | 29.720 | 21.229 | 1.669 | 1.393 |
| Current Assets | 1.248 | 5.159 | 10.924 | 61.352 | 76.397 | 117.691 | 74.902 | 14.890 | 27.773 | 37.058 |
| Inventories | 0 | 408 | 7.252 | 6.566 | 5.158 | 5.406 | 4.790 | 4.352 | 9.839 | 6.055 |
| Receivables | 0 | 3.568 | 0 | 875 | 449 | 415 | 445 | 419 | 519 | 25.959 |
| Cash | 1.248 | 1.183 | 3.672 | 53.910 | 70.790 | 111.871 | 69.666 | 10.120 | 17.415 | 5.044 |
| Shareholders Funds | 1.248 | 787 | 9.696 | 55.666 | 70.016 | 116.910 | 93.110 | 30.589 | 24.360 | 31.604 |
| Social Capital | 45 | 178 | 175 | 172 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 0 | 4.480 | 1.653 | 6.188 | 6.873 | 2.944 | 11.512 | 5.530 | 5.082 | 6.848 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Schmidt Pharmamed Srl